OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
A strong digital backbone is foundational in driving innovation.
Linking structure with function is paramount.
Reviewing mAbs that failed after reaching Phase III trials.
September 28, 2022
A combination of eye imaging techniques and adaptive optics has revealed key details of choroideremia.
The dedicated solid-state research and development suite is designed to promote discovery of novel polymorph, salt, and cocrystal forms.
September 15, 2022
Using an orthogonal approach to lipid nanoparticle analysis can increase the odds of project success.
September 14, 2022
A thorough understanding of both regulatory requirements and study challenges can help develop and validate the appropriate methods for a bioanalytical study program.
An early drug candidate screening strategy should incorporate clear targets to lessen late-stage failure.
September 09, 2022
Avance Clinical’s acquisition of C3 Research Associates expands its CRO services to North America.
September 02, 2022
Roche’s Digital LightCycler System is designed to aid in diagnostics for cancer, genetic disease, and infection.
September 01, 2022
A holistic view of the product, manufacturing, and ultimate use of the viral vector is required.
It is important to understand regulatory requirements and study challenges to develop and validate the appropriate methods for a bioanalytical study program at the clinical stage.
August 15, 2022
CYTENA’s B.SIGHT cell dispenser is designed to streamline single-cell isolation in microbiology research.